Kalaris Therapeutics Inc (KLRS)

Finanzdaten der Kalaris Therapeutics Inc-Aktie (KLRS)

*Alle Zahlen in Millionen

Enddatum des Zeitraums	2026-06-30	2026-03-31	2025-12-31	2025-09-30	2025-06-30
Periodenlänge	3 Monate	3 Monate	3 Monate	3 Monate	3 Monate
	4.67%12.39	11.83	10.80	12.74	12.26
Research and Development	19.10%9.02	7.57	7.16	9.13	8.44
Interest Income/Expense	-	-	-	-	-
Operating Income/Loss	4.67%-12.39	-11.83	-10.80	-12.74	-12.26
Nonoperating Income/Loss	10.85%0.87	0.98	0.80	0.85	0.91
	6.07%-11.52	-10.86	-10.00	-11.89	-11.35
Attributable To Parent	6.07%-11.52	-10.86	-10.00	-11.89	-11.35
Basic Average Shares	0.31%23.80	23.72	-	18.70	18.70
Diluted Average Shares	0.31%23.80	23.72	-	18.70	18.70
Basic Earnings Per Share	4.35%-0.48	-0.46	-	-0.64	-0.61
Diluted Earnings Per Share	4.35%-0.48	-0.46	-	-0.64	-0.61